Allegra Managed Care Talks Ongoing: Aventis Expects No “Major Shifts”
Executive Summary
Aventis does not expect any "major shifts" in Allegra reimbursement as the company renews managed care contracts for 2004, Investor Relations Head Arvind Sood told analysts Oct. 30
You may also be interested in...
Schering Sales Force Recruitment Is 80% Complete; Morale Remains High
Recruitment for Schering-Plough's sales force expansion is 80% complete, Global Pharmaceutical President Carrie Cox told investors during a year-end conference call Jan. 26
Schering Sales Force Recruitment Is 80% Complete; Morale Remains High
Recruitment for Schering-Plough's sales force expansion is 80% complete, Global Pharmaceutical President Carrie Cox told investors during a year-end conference call Jan. 26
Aventis Sees “Blurring” Of Rx/OTC Distinctions; Change Coming For Allegra?
The antihistamine market can no longer comfortably be divided between prescription and OTC entrants, Aventis Chief Operating Officer Richard Markham suggested during the J.P. Morgan health care conference in San Francisco Jan. 13